Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flibanserin Safety Study in Premenopausal European Women with HSDD
NCT00601367Phase 3Completed
- Sponsor
- Sprout Pharmaceuticals
- Start
- Jan 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of flibanserin in hypoactive sexual desire disorder (HSDD), sponsored by Sprout Pharmaceuticals. Started Jan 2008; status: completed.
02
Drugs
flibanserin
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT00601367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601367.